CD33 and neoplasm: The colocalisation and accumulation of NLRP3 and FATP2 with CD33 in fatty grafts demonstrated that NLRP3 and FATP2 might modulate MDSCs in post-transplant tumour recurrence (Fig. 1D and Fig. S1F).